Pless, Miklos
Kantonsspital Winterthur
7 papers on CoChatORCID 0000-0001-5121-4402
Most cited papers
- Verified
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
Hanna, N., Shepherd, F. A., Fossella, F. V., Pereira, J. R., De Marinis, F., von Pawel, J., Gatzemeier, U., Tsao, T. C. Y., Pless, M., Muller, T., et al. (2004) · Journal of Clinical Oncology
Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment
Cited by 2,426
- Verified
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial
de Langen, A. J., Johnson, M. L., Mazieres, J., Dingemans, A.-M. C., Mountzios, G., Pless, M., Wolf, J., Schuler, M., Lena, H., Skoulidis, F., et al. (2023) · The Lancet
Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment
Cited by 619
- Verified
Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): An international, multicentre, single-arm, phase 2 trial
Rosell, R., Dafni, U., Felip, E., Curioni-Fontecedro, A., Gautschi, O., Peters, S., Massutí, B., Palmero, R., Aix, S. P., Carcereny, E., et al. (2017) · The Lancet Respiratory Medicine
Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research
Cited by 182
- Verified
Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer—The ETOP NICOLAS trial
Peters, S., Felip, E., Dafni, U., Belka, C., Guckenberger, M., Irigoyen, A., Nadal, E., Becker, A., Vees, H., Pless, M., et al. (2019) · Lung Cancer
Lung Cancer Diagnosis and TreatmentCancer Immunotherapy and Biomarkers
Cited by 162
- Verified
Tumor treating fields: concept, evidence and future
Pless, M., & Weinberg, U. (2011) · Expert Opinion on Investigational Drugs
Electromagnetic Fields and Biological EffectsGlioma Diagnosis and Treatment
Cited by 78
- Verified
Predictive value of radiological response, pathological response and relapse-free survival for overall survival in neoadjuvant immunotherapy trials: pooled analysis of 29 clinical trials
Nie, R., Chen, F., Provencio, M., Wang, Y., van den Ende, T., van Laarhoven, H. W. M., Yuan, S., Pless, M., Hayoz, S., Zhou, Z., et al. (2023) · European Journal of Cancer
Cancer Immunotherapy and BiomarkersBreast Cancer Treatment Studies
Cited by 25
- Verified
A clinical trial of group-based body psychotherapy to improve bodily disturbances in post-treatment cancer patients in combination with randomized controlled smartphone-triggered bodily interventions (KPTK): Study protocol
Grossert, A., Meffert, C., Hess, V., Rochlitz, C., Pless, M., Hunziker, S., Wössmer, B., Geuter, U., Meinlschmidt, G., & Schaefert, R. (2019) · BMC Psychology
Cancer survivorship and carePsychosomatic Disorders and Their Treatments
Cited by 6
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free